The aim of this study was to investigate the feasibility of application of a 3D-printed megaprosthesis with hemiarthroplasty design for defects of the distal humerus or proximal ulna following tumour resection. From June 2018 to January 2020, 13 patients with aggressive or malignant tumours involving the distal humerus (n = 8) or proximal ulna (n = 5) were treated by en bloc resection and reconstruction with a 3D-printed megaprosthesis with hemiarthroplasty, designed in our centre. In this paper, we summarize the baseline and operative data, oncological outcome, complication profiles, and functional status of these patients.Aims
Methods
To investigate the benefits of denosumab in combination with nerve-sparing surgery for treatment of sacral giant cell tumours (GCTs). This is a retrospective cohort study of patients with GCT who presented between January 2011 and July 2017. Intralesional curettage was performed and patients treated from 2015 to 2017 also received denosumab therapy. The patients were divided into three groups: Cohort 1: control group (n = 36); cohort 2: adjuvant denosumab group (n = 9); and cohort 3: neo- and adjuvant-denosumab group (n = 17).Aims
Methods
The aim of this study was to describe the use of 3D-printed sacral endoprostheses to reconstruct the pelvic ring and re-establish spinopelvic stability after total We retrospectively reviewed 32 patients who underwent TES in our hospital between January 2015 and December 2017. We divided the patients into three groups on the basis of the method of reconstruction: an endoprosthesis group (n = 10); a combined reconstruction group (n = 14), who underwent non-endoprosthetic combined reconstruction, including anterior spinal column fixation; and a spinopelvic fixation (SPF) group (n = 8), who underwent only SPF. Spinopelvic stability, implant survival (IS), intraoperative haemorrhage rate, and perioperative complication rate in the endoprosthesis group were documented and compared with those of other two groups.Aims
Patients and Methods
The purpose of the present study was to compare the clinical and radiographic results after TKA using a patellofemoral design modified prosthesis and its predecessor. The other purpose was to investigate whether the use of the recent prosthesis increase the risk of posterior tibial cortex injury or patellar fracture. The clinical and radiographic results of 300 knees which underwent TKA using the Attune®prosthesis (group A) were compared with those in a paired match-control group who underwent TKA using the P.F.C. Sigma® prosthesis (group B). The preoperative demographic data between the 2 groups did not differ significantly. The WOMAC, Feller and Kujala scores, and range of motion (ROM) were compared. The minimal distance between the tibial component stem to posterior tibial cortex, and the remnant patella thickness were compared.Objective
Materials and Methods
Although total knee arthroplasty (TKA) in end-stage hemophilic arthropathy can reduce the severe joint pain and improve the functional disability, it is technically demanding. In addition, it has generally reported a high rate of complication including periprosthetic joint infection (PJI) and component loosening up to 20%. Although the Knee Society classification system of TKA complication was introduced, the complications of TKA in hemophilic arthropathy has not stratified using this classification system in previous articles to the best of our knowledge. The purpose of this study was to evaluate the mid-term outcomes and complications of TKA in hemophilic arthropathy. The study retrospectively reviewed 131 consecutive primary TKAs (102 patients) in single institute. The mean patient age was 41.0 years and mean follow-up time was 6.4 years. The clinical and radiographic results were evaluated. The complications were categorized according to the classification system of the Knee Society for TKA complications.Introduction
Methods
The knowledge about the common mode of failure and each period in primary and revision TKAs offers useful information to prevent those kinds of failure in each surgery. However, there has been limited report that simultaneously compared the mode of failure between primary and revision TKAs using single prosthesis. We compared the survival rate, mode of failure, and periods of each mode of failure between primary and revision TKAs. A consecutive cohort of 1606 knees (1174 patients) of primary TKA and 258 knees (224 patients) of revision TKA using P.F.C® prosthesis was retrospectively reviewed. The mean follow-up periods of primary and revision TKAs were 10.2 and 10.8 years, respectively. We compared the above variables between primary and revision TKAs.Background
Methods
The aims of this retrospective study were to report the feasibility
of using 3D-printing technology for patients with a pelvic tumour
who underwent reconstruction. A total of 35 patients underwent resection of a pelvic tumour
and reconstruction using 3D-printed endoprostheses between September
2013 and December 2015. According to Enneking’s classification of
bone defects, there were three Type I lesions, 12 Type II+III lesions,
five Type I+II lesions, two Type I+II+III lesions, ten type I+II+IV
lesions and three type I+II+III+IV lesions. A total of three patients
underwent reconstruction using an iliac prosthesis, 12 using a standard
hemipelvic prosthesis and 20 using a screw-rod connected hemipelvic
prosthesis.Aims
Patients and Methods
Short metaphyseal fitting femoral stems convey stress to proximal femur and have no distal fixation. They have advantages in that there is no thigh pain and no bone loss due to stress shielding, but there is a concern for weakened fixation. So the authors evaluated whether short metaphyseal fitting femoral stems, which have only metaphyseal and no diaphyseal fixation, can acquire sufficient stability. 39 cases of 36 patients who undervent uncemented total hip arthroplasty with DePuy ProximaTM (Johnson & Johnson orthopaedics, New Milton, UK) short metaphyseal fitting femoral stems from August 2009 to September 2011 were retrospectively evaluated. There were 19 male and 20 female cases. The mean follow-up period was 35.8(21.8∼49.2) months. Harris hip scores, WOMAC scores, UCLA scores, and presence of femoral pain were evaluated to assess clinical outcome. Femoral radiolucency in coronal and sagittal views of the hip, femoral stem loosening, and displacement was measured to evaluate radiological outcome. Distance between femoral stem and cortical bone was also measured to assess the relationship with radiolucency and loosening according to degree of contact.Purpose
Materials & methods